H.F. 4664 Summary

• Shields persons who design, manufacture, label, sell, distribute, or donate COVID-19 qualified products (PPE, medical devices, medications, tests) from civil liability when used by government entities, health care professionals, facilities, first responders, or essential businesses, except when the person had actual knowledge the product was defective and acted with complete indifference to substantial risks or intent to cause harm.

• Prohibits civil actions alleging COVID-19-related injury, death, or economic loss unless the claimant was diagnosed with COVID-19 symptoms, required inpatient hospitalization, or experienced serious illness (inability to perform usual activities for 14+ days), with exception for intentional exposure or harm.

• Eliminates duty of premises owners, lessors, lessees, or occupants to eliminate COVID-19 risks or warn entrants of such risks, and limits liability to only willful, wanton, reckless disregard of substantial unnecessary exposure risk or intentional exposure (excludes workers' compensation claims).

• Provides liability immunity for persons conducting business whose COVID-19-related acts or omissions complied with or were consistent with written federal, state, or local government guidance applicable at the time of the alleged act or omission.

• All provisions are effective retroactively from March 13, 2020, and apply to causes of action accruing on or after that date.